Many providers use lower starting doses or slower escalation schedules for patients with significant early side effects
CVOTs cardiovascular outcome trials, T2DM type 2 diabetes mellitus, GLP-1RAs GLP-1 receptor agonists, HbA1c glycated hemoglobin, ACS acute coronary syndrome, OAD oral antidiabetic drugs, eGFR estimated glomerular filtration rate, UACR urine albumin-creatinine ratio, CVD cardiovascular disease, BMI body mass index, T1DM type 1 diabetes mellitus, DPP-4i DPP-4 inhibitor, HR hazard ratio, CI confidence interval, HF heart failure Outside of those major clinical trials, a nationwide retrospective study in Taiwan, China, evaluated the effects of DPP-4i in elderly patients with T2DM relative to cardiovascular outcomes
doi: 10.1249/mss.0b013e3180383da5
Clarkson has not publicly discussed the financial aspect of her treatment
When to Stay at Your Current Semaglutide Dose Many people achieve their weight loss goals without ever reaching the maximum recommended dose, and remaining at a lower, well-tolerated dose is medically sound if results are steady and side effects are minimal
FOX 9 has extensively reported on pharmacy benefit managers as the companies faced a review by the FTC, while looking at the impact they've had on small pharmacies
